Achieve Life Sciences, Inc. (ACHV)
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.
$152.13M
Mr. Richard Stewart
16.00
Seattle, WASHINGTON
Oct 12, 1995
-4.14
$-1.07
1.08
4.56
0.00%
-5.65
-0.10
3.68
0.00
4.56
-42.50%
-116.78%
Similar stocks (16)
Apellis Pharmaceuticals, Inc.
APLS
Day One Biopharmaceuticals, Inc.
DAWN
iTeos Therapeutics, Inc.
ITOS
Inozyme Pharma, Inc.
INZY
TScan Therapeutics, Inc.
TCRX
Acumen Pharmaceuticals, Inc.
ABOS
Coherus BioSciences, Inc.
CHRS
Assembly Biosciences, Inc.
ASMB
X4 Pharmaceuticals, Inc.
XFOR
CytomX Therapeutics, Inc.
CTMX
Spero Therapeutics, Inc.
SPRO
Immix Biopharma, Inc.
IMMX
NextCure, Inc.
NXTC
Bolt Biotherapeutics, Inc.
BOLT
CNS Pharmaceuticals, Inc.
CNSP
Hepion Pharmaceuticals, Inc.
HEPA
ETF Exposure (23)
JPMorgan Short Duration Core Plus ETF
JSCP
0.09%
JPMorgan Core Plus Bond ETF
JCPB
0.07%
iShares Micro-Cap ETF
IWC
0.03873%
Vanguard Russell 2000 Growth Index Fund
VTWG
0.01%
Vanguard Russell 2000 Index Fund
VTWO
0.01%
iShares Russell 2000 Growth ETF
IWO
0.0067%
iShares Russell 2000 ETF
IWM
0.00525%
iShares Russell 2000 Value ETF
IWN
0.00418%
ProShares Ultra Russell2000
UWM
0.002122098033671738%
ProShares UltraPro Russell2000
URTY
0.0010455876412039404%
ProShares Hedge Replication ETF
HDG
8.812080937871958e-4%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Russell 2000 Value Index Fund
VTWV
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (16)
Apellis Pharmaceuticals, Inc.
APLS
Day One Biopharmaceuticals, Inc.
DAWN
iTeos Therapeutics, Inc.
ITOS
Inozyme Pharma, Inc.
INZY
TScan Therapeutics, Inc.
TCRX
Acumen Pharmaceuticals, Inc.
ABOS
Coherus BioSciences, Inc.
CHRS
Assembly Biosciences, Inc.
ASMB
X4 Pharmaceuticals, Inc.
XFOR
CytomX Therapeutics, Inc.
CTMX
Spero Therapeutics, Inc.
SPRO
Immix Biopharma, Inc.
IMMX
NextCure, Inc.
NXTC
Bolt Biotherapeutics, Inc.
BOLT
CNS Pharmaceuticals, Inc.
CNSP
Hepion Pharmaceuticals, Inc.
HEPA
ETF Exposure (23)
JPMorgan Short Duration Core Plus ETF
JSCP
0.09%
JPMorgan Core Plus Bond ETF
JCPB
0.07%
iShares Micro-Cap ETF
IWC
0.03873%
Vanguard Russell 2000 Growth Index Fund
VTWG
0.01%
Vanguard Russell 2000 Index Fund
VTWO
0.01%
iShares Russell 2000 Growth ETF
IWO
0.0067%
iShares Russell 2000 ETF
IWM
0.00525%
iShares Russell 2000 Value ETF
IWN
0.00418%
ProShares Ultra Russell2000
UWM
0.002122098033671738%
ProShares UltraPro Russell2000
URTY
0.0010455876412039404%
ProShares Hedge Replication ETF
HDG
8.812080937871958e-4%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Russell 2000 Value Index Fund
VTWV
0%
Vanguard Extended Market Index Fund
VXF
0%